Evidence map›Paper›PMID 41647754›Full record

ReviewFrontiers in human neuroscience2026

Advances in neuroimaging in cancer-related cognitive impairment.

Jinxin Li, Feiyun Cui, Yuanshan Yang, Qingting Zhang, Lijiao Zeng, Yulun Li, Yunxian Zhang, Jinbai Huang, Wei Wang

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Frontiers in human neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Jinxin Li *Nuclear Medicine Department, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Feiyun Cui *Department of Radiology, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Yuanshan YangNuclear Medicine Department, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Qingting ZhangNuclear Medicine Department, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Lijiao ZengNuclear Medicine Department, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Yulun LiNuclear Medicine Department, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Yunxian ZhangDepartment of Medical Imaging, Health Science Center, Yangtze University, Jingzhou, Hubei, China.
Jinbai HuangNuclear Medicine Department, The First Affiliated Hospital of Yangtze University, Jingzhou, Hubei, China.
Wei WangDepartment of Rehabilitation Radiology, Beijing Rehabilitation Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cancer-related cognitive impairment (CRCI) is a cognitive dysfunction of the brain caused by the tumor itself and antitumor treatments such as radiotherapy, chemotherapy, endocrine therapy, and surgery. As a common complication of cancer, CRCI significantly affects patients' quality of life. In recent years, the neurobiological mechanisms of CRCI have garnered widespread attention. Research indicates that cancer-related therapies lead to CRCI by affecting brain structure, function, metabolism, and blood perfusion. Various neuroimaging techniques, including magnetic resonance imaging (MRI), positron emission tomography (PET), and electroencephalography (EEG), have been extensively employed to investigate the neurobiological underpinnings of CRCI. This article reviews recent advancements in neuroimaging research on CRCI, focusing on its influencing factors and the neural mechanisms underlying different cognitive domains, and summarizes findings from relevant animal model studies.

Indexed as

brain functionCRCImalignant tumorsneuroimagingradiotherapy

Identifiers

PMID41647754
PMCPMC12868142

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.